Aberrant MET mutations resulted in c-MET overexpression in endometrial cancer tissues (Figure 2B), similar to that seen in lung cancer, indicating that c-MET overexpression alone can induce oncogenic transformation in vitro and in vivo [17,18,19,20]. Here, MET is linked to endometrial cancer.